{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:08Z","timestamp":1786980488028,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T00:00:00Z","timestamp":1516665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10067-018-3992-7","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T14:13:33Z","timestamp":1516716813000},"page":"1695-1700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Tocilizumab reduces complement C3 and C4 serum levels in rheumatoid arthritis patients"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5807-6601","authenticated-orcid":false,"given":"Ciro","family":"Romano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Del Mastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ausilia","family":"Sellitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Solaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Cuomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,23]]},"reference":[{"key":"3992_CR1","first-page":"1","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh JA, Saag KG, Bridges SL Jr et al (2016) 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68:1\u201326","journal-title":"Arthritis Rheumatol"},{"issue":"10031","key":"3992_CR2","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","volume":"387","author":"PM Villiger","year":"2016","unstructured":"Villiger PM, Adler S, Kuchen S, Wermelinger F, Dan D, Fiege V, B\u00fctikofer L, Seitz M, Reichenbach S (2016) Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 387(10031):1921\u20131927. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(16)00560-2","journal-title":"Lancet"},{"issue":"12","key":"3992_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrrheum.2014.127","volume":"10","author":"LH Calabrese","year":"2014","unstructured":"Calabrese LH, Rose-John S (2014) IL-6 biology: implications for clinical targeting in rheumatic disease. Nat Rev Rheumatol 10(12):720\u2013727. \nhttps:\/\/doi.org\/10.1038\/nrrheum.2014.127","journal-title":"Nat Rev Rheumatol"},{"key":"3992_CR4","volume":"5","author":"JA Singh","year":"2017","unstructured":"Singh JA, Hossain A, Mudano AS et al (2017) Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Cochrane Database Syst Rev 5:CD012657","journal-title":"Cochrane Database Syst Rev"},{"key":"3992_CR5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3899\/jrheum.130466","volume":"41","author":"T Koike","year":"2014","unstructured":"Koike T, Harigai M, Inokuma S et al (2014) Effectiveness and safety of tocilizumab: postmarketing surveillance of 7901 patients with rheumatoid arthritis in Japan. J Rheumatol 41:15\u201323","journal-title":"J Rheumatol"},{"key":"3992_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/OARRR.S14563","volume":"4","author":"SV Townes","year":"2012","unstructured":"Townes SV, Furst DE, Thenkondar A (2012) The impact of tocilizumab on physical function and quality of life in patients with rheumatoid arthritis: a systematic literature review and interpretation. Open Access Rheumatol 4:87\u201392. \nhttps:\/\/doi.org\/10.2147\/OARRR.S14563","journal-title":"Open Access Rheumatol"},{"key":"3992_CR7","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/ard.2006.068064","volume":"66","author":"N Nishimoto","year":"2007","unstructured":"Nishimoto N, Hashimoto J, Miyasaka N et al (2007) Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomized controlled trial of tocilizumab. Ann Rheum Dis 66:1162\u20131167","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"3992_CR8","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1136\/annrheumdis-2015-207872","volume":"75","author":"C Gabay","year":"2016","unstructured":"Gabay C, McInnes IB, Kavanaugh A, Tuckwell K, Klearman M, Pulley J, Sattar N (2016) Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis 75(10):1806\u20131812. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2015-207872","journal-title":"Ann Rheum Dis"},{"key":"3992_CR9","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/rheumatology\/keu168","volume":"53","author":"AP Malaviya","year":"2014","unstructured":"Malaviya AP, Ledingham J, Bloxham J et al (2014) The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis. Rheumatology 53:1344\u20131346","journal-title":"Rheumatology"},{"key":"3992_CR10","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3992_CR11","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter CA, Jones SA (2015) IL-6 as a keystone cytokine in health and disease. Nat Immunol 16(5):448\u2013457. \nhttps:\/\/doi.org\/10.1038\/ni.3153","journal-title":"Nat Immunol"},{"issue":"6\u20137","key":"3992_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ejcb.2011.09.008","volume":"91","author":"JG Bode","year":"2012","unstructured":"Bode JG, Albrecht U, H\u00e4ussinger D, Heinrich PC, Schaper F (2012) Hepatic acute phase proteins\u2014regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-\u03baB-dependent signaling. Eur J Cell Biol 91(6\u20137):496\u2013505. \nhttps:\/\/doi.org\/10.1016\/j.ejcb.2011.09.008","journal-title":"Eur J Cell Biol"},{"issue":"4","key":"3992_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00281-017-0619-z","volume":"39","author":"M Noack","year":"2017","unstructured":"Noack M, Miossec P (2017) Selected cytokine pathways in rheumatoid arthritis. Semin Immunopathol 39(4):365\u2013383. \nhttps:\/\/doi.org\/10.1007\/s00281-017-0619-z","journal-title":"Semin Immunopathol"},{"key":"3992_CR14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10875-015-0137-5","volume":"35","author":"AJ Turley","year":"2015","unstructured":"Turley AJ, Gathmann B, Bangs C et al (2015) Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe. J Clin Immunol 35:199\u2013205","journal-title":"J Clin Immunol"},{"key":"3992_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cca.2016.12.017","volume":"465","author":"P Vignesh","year":"2017","unstructured":"Vignesh P, Rawat A, Sharma M, Singh S (2017) Complement in autoimmune diseases. Clin Chim Acta 465:123\u2013130. \nhttps:\/\/doi.org\/10.1016\/j.cca.2016.12.017","journal-title":"Clin Chim Acta"},{"issue":"1","key":"3992_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/imr.12462","volume":"274","author":"M Martin","year":"2016","unstructured":"Martin M, Blom AM (2016) Complement in removal of the dead\u2014balancing inflammation. Immunol Rev 274(1):218\u2013232. \nhttps:\/\/doi.org\/10.1111\/imr.12462","journal-title":"Immunol Rev"},{"issue":"17","key":"3992_CR17","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s40265-017-0829-7","volume":"77","author":"LJ Scott","year":"2017","unstructured":"Scott LJ (2017) Tocilizumab: a review in rheumatoid arthritis. Drugs 77(17):1865\u20131879. \nhttps:\/\/doi.org\/10.1007\/s40265-017-0829-7","journal-title":"Drugs"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-3992-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-3992-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-3992-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T03:05:33Z","timestamp":1526007933000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-3992-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,23]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["3992"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-3992-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,23]]}}}